Autres langues PYC Therapeutics Limited

Actions

PYC

AU000000PYC7

Marché Fermé - Australian S.E. Autres places de cotation 08:10:44 26/04/2024			Varia. 5j.	Varia. 1 janv.
0,092 ^AUD	-1,08 %		+1,10 %	-16,36 %

22/04	Les actions australiennes rebondissent grâce à l'apaisement des tensions au Moyen-Orient et dans l'attente d'un rapport sur l'inflation locale	MT
10/04	PYC Therapeutics lève 13,5 millions de dollars australiens par le biais d'une offre au détail et annonce un placement de 21,2 millions de dollars australiens pour combler le manque à gagner.	MT

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Australian Shares Rebound Amid Easing Middle East Tensions, Ahead of Local Inflation Data	22/04
PYC Therapeutics Confirms Safety, Tolerability of Kidney Medication in Animal Study	22/04
PYC Therapeutics Raises AU$13.5 Million via Retail Offer; AU$21.2 Million Retail Shortfall Placement Announced	10/04
PYC Therapeutics Raises AU$40 Million via Entitlement Offer	18/03
PYC Therapeutics to Raise Up to AU$75 Million for Advancing Drug Candidates	14/03
PYC Therapeutics Limited Reports Earnings Results for the Half Year Ended December 31, 2023	29/02
PYC Therapeutics Receives AU$4.5 Million Upfront Fee for Drug Discovery Collaboration	16/02
PYC Therapeutics to Launch Google Cloud-Hosted Drug Discovery Project; Shares Fall 5%	02/01
Pyc Therapeutics Announces the Results of A Study Conducted in Human 3-Dimensional Models Derived from Patients with End-Stage Renal Failure Due to Autosomal Dominant Polycystic Kidney Disease	13/11
PYC Therapeutics Completes Dosing in Second Patient Cohort for Retinitis Pigmentosa Clinical Trial	03/11
PYC Reports Positive Results from Preclinical Studies of Rare Eye Disease Drug	05/10/23
PYC Therapeutics Advances to Second Dose Cohort of Phase 1 Trial Following Safety Clearance	22/09/23
PYC Therapeutics Limited Reports Earnings Results for the Full Year Ended June 30, 2023	31/08/23
PYC Therapeutics Limited Announces US FDA Designates PYC's Lead as a Fast Track Development Program	11/08/23
PYC Therapeutics Raises Vision Pharma Shareholding to 96.2%	10/08/23
PYC Therapeutics' RP11 Investigational Drug Candidate Secures Fast Track Designation from US FDA; Shares Climb 3%	02/08/23
PYC Therapeutics Completes Toxicology Testing of Retinitis Pigmentosa Medication	18/07/23
PYC Therapeutics Doses First Patient in Blinding Eye Disease Trial	30/06/23
Pyc Appoints Andrew Taylor as Joint Company Secretary	01/06/23
PYC Therapeutics to Raise AU$30 Million in Placement	11/05/23

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues PYC Therapeutics Limited

Actions

PYC

AU000000PYC7

Autres langues

Filtres